UBA5 p.Tyr285*
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PVS1PM2
The NM_024818.6(UBA5):c.855C>G(p.Tyr285*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_024818.6 stop_gained
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_024818.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| UBA5 | MANE Select | c.855C>G | p.Tyr285* | stop_gained | Exon 9 of 12 | NP_079094.1 | Q9GZZ9-1 | ||
| UBA5 | c.687C>G | p.Tyr229* | stop_gained | Exon 9 of 12 | NP_001307139.1 | Q9GZZ9-2 | |||
| UBA5 | c.687C>G | p.Tyr229* | stop_gained | Exon 9 of 12 | NP_938143.1 | Q9GZZ9-2 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| UBA5 | TSL:1 MANE Select | c.855C>G | p.Tyr285* | stop_gained | Exon 9 of 12 | ENSP00000348565.4 | Q9GZZ9-1 | ||
| UBA5 | TSL:1 | c.687C>G | p.Tyr229* | stop_gained | Exon 9 of 12 | ENSP00000418807.2 | Q9GZZ9-2 | ||
| NPHP3-ACAD11 | TSL:2 | c.635+6624G>C | intron | N/A | ENSP00000488520.1 | A0A0J9YXS1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.